GB1582763A - Live influenza virus vaccine and preparation thereof - Google Patents

Live influenza virus vaccine and preparation thereof Download PDF

Info

Publication number
GB1582763A
GB1582763A GB24913/77A GB2491377A GB1582763A GB 1582763 A GB1582763 A GB 1582763A GB 24913/77 A GB24913/77 A GB 24913/77A GB 2491377 A GB2491377 A GB 2491377A GB 1582763 A GB1582763 A GB 1582763A
Authority
GB
United Kingdom
Prior art keywords
influenza virus
vaccine
strain
virus
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB24913/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline RIT
Original Assignee
SmithKline RIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE168041A external-priority patent/BE843094R/fr
Application filed by SmithKline RIT filed Critical SmithKline RIT
Publication of GB1582763A publication Critical patent/GB1582763A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB24913/77A 1976-06-18 1977-06-15 Live influenza virus vaccine and preparation thereof Expired GB1582763A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE168041A BE843094R (fr) 1976-06-18 1976-06-18 Vaccins viraux vivants contre la grippe et leur procede de fabrication

Publications (1)

Publication Number Publication Date
GB1582763A true GB1582763A (en) 1981-01-14

Family

ID=3842893

Family Applications (1)

Application Number Title Priority Date Filing Date
GB24913/77A Expired GB1582763A (en) 1976-06-18 1977-06-15 Live influenza virus vaccine and preparation thereof

Country Status (5)

Country Link
AU (1) AU513734B2 (enExample)
CH (1) CH610347A5 (enExample)
FR (1) FR2354778A2 (enExample)
GB (1) GB1582763A (enExample)
NL (1) NL7706710A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318903A (en) * 1978-07-12 1982-03-09 Smithkline-Rit Live influenza virus vaccine and the preparation thereof
US4278662A (en) * 1979-10-16 1981-07-14 Smith Kline - Rit Attenuated influenza type A virus vaccine

Also Published As

Publication number Publication date
FR2354778B2 (enExample) 1980-01-18
AU2611577A (en) 1978-12-21
NL7706710A (nl) 1977-12-20
FR2354778A2 (fr) 1978-01-13
AU513734B2 (en) 1980-12-18
CH610347A5 (en) 1979-04-12

Similar Documents

Publication Publication Date Title
Tamura et al. Cross‐protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules
Couch et al. Induction of partial immunity to influenza by a neuraminidase-specific vaccine
Henle Interference phenomena between animal viruses: a review
Swayne et al. Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines
Sikes et al. Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine
AU770923B2 (en) Inactivated influenza virus vaccine for nasal or oral administration
Beutner et al. Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection
Cox et al. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
EP0891420A1 (en) Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
US4338296A (en) Influenza virus and process of producing a vaccine therefrom
Chambers et al. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge
Fagiolo et al. Humoral and cellular immune response to influenza virus vaccination in aged humans
FI59535B (fi) Foerfarande att tillverka levande virusvaccin foer newcastle-sjukdom
US4318903A (en) Live influenza virus vaccine and the preparation thereof
US4029763A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
Bender et al. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza
US3953592A (en) Live influenza virus vaccines and preparation thereof
US3897549A (en) Herpes simplex type 2 virus vaccine and method of production and use
CA2700937C (en) Method of eliciting an immune response against pandemic influenza virus
CA1152895A (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
Morris et al. Antigenic relationship of 1961–1963 A2 influenza viruses to prototype A2 1957 strain
GB1582763A (en) Live influenza virus vaccine and preparation thereof
Kilbourne et al. Hemagglutinin mutants of swine influenza virus differing in replication characteristics in their natural host
US3962423A (en) Live influenza type B virus vaccines and preparation thereof

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee